Merck & Co., Inc.West Point, United States
Disclosure information not submitted.
SP05C - Non-interventional Post-authorization Safety Studies and Post-authorization Effectiveness Studies for Oncology Drugs: A Systematic Review
Tuesday, August 24, 20213:30 PM – 4:45 PM US Eastern Time